1. Cancer Biology
  2. Developmental Biology

Tumor suppression in basal keratinocytes via dual non-cell-autonomous functions of a Na,K-ATPase beta subunit

  1. Julia Hatzold  Is a corresponding author
  2. Filippo Beleggia
  3. Hannah Herzig
  4. Janine Altmüller
  5. Peter Nürnberg
  6. Wilhelm Bloch
  7. Bernd Wollnik
  8. Matthias Hammerschmidt  Is a corresponding author
  1. University of Cologne, Germany
  2. German Sport University Cologne, Germany
  3. University Hospital Cologne, Germany
https://doi.org/10.7554/eLife.14277
Share this article
Cite this article
  1. Julia Hatzold
  2. Filippo Beleggia
  3. Hannah Herzig
  4. Janine Altmüller
  5. Peter Nürnberg
  6. Wilhelm Bloch
  7. Bernd Wollnik
  8. Matthias Hammerschmidt
(2016)
Tumor suppression in basal keratinocytes via dual non-cell-autonomous functions of a Na,K-ATPase beta subunit
eLife 5:e14277.
https://doi.org/10.7554/eLife.14277
  2. Download BibTeX
  3. Download .RIS

Abstract

Molecular pathways underlying tumor suppression are incompletely understood. Here, we identify cooperative non-cell-autonomous functions of one and the same gene as a novel mechanism of tumor suppression in basal keratinocytes of zebrafish embryos. A loss-of-function mutation in atp1b1a, encoding the beta subunit of a Na,K-ATPase pump, causes edema and epidermal malignancy. Strikingly, basal cell carcinogenesis only occurs when Atp1b1a function is compromised in both the overlying periderm (resulting in compromised epithelial polarity and adhesiveness) and in kidney and heart (resulting in hypotonic stress). Blockade of the ensuing PI3K-AKT-mTORC1-NFκB-MMP9 pathway activation in basal cells, as well as systemic isotonicity, prevents malignant transformation. Our results identify hypotonic stress as a thus far unrecognized contributor to tumor development and establish a novel paradigm of tumor suppression.

Article and author information

Author details

  1. Julia Hatzold

    Institute for Zoology, Developmental Biology Unit, University of Cologne, Cologne, Germany
    For correspondence
    jhatzold@uni-koeln.de
    Competing interests
    The authors declare that no competing interests exist.

  2. Filippo Beleggia

    Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.

  3. Hannah Herzig

    Institute of Cardiology and Sports Medicine, German Sport University Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.

  4. Janine Altmüller

    Institute of Human Genetics, University Hospital Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.

  5. Peter Nürnberg

    Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.

  6. Wilhelm Bloch

    Institute of Cardiology and Sports Medicine, German Sport University Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.

  7. Bernd Wollnik

    Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.

  8. Matthias Hammerschmidt

    Institute for Zoology, Developmental Biology Unit, University of Cologne, Cologne, Germany
    For correspondence
    mhammers@uni-koeln.de
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Didier Y R Stainier, Max Planck Institute for Heart and Lung Research, Germany

Ethics

Animal experimentation: All zebrafish experiments were approved by the national animal care committees (LANUV Nordrhein-Westfalen; 8.87-50.10.31.08.129; 84-02.04.2012.A251; City of Cologne; 576.1.36.6.3.01.10 Be) and the University of Cologne.

Version history

  1. Received: January 7, 2016
  2. Accepted: May 28, 2016
  3. Accepted Manuscript published: May 30, 2016 (version 1)
  4. Accepted Manuscript updated: June 1, 2016 (version 2)
  5. Version of Record published: July 15, 2016 (version 3)

Copyright

© 2016, Hatzold et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,704
    views
  • 572
    downloads
  • 21
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Julia Hatzold
  2. Filippo Beleggia
  3. Hannah Herzig
  4. Janine Altmüller
  5. Peter Nürnberg
  6. Wilhelm Bloch
  7. Bernd Wollnik
  8. Matthias Hammerschmidt
(2016)
Tumor suppression in basal keratinocytes via dual non-cell-autonomous functions of a Na,K-ATPase beta subunit
eLife 5:e14277.
https://doi.org/10.7554/eLife.14277

Share this article

https://doi.org/10.7554/eLife.14277

Categories and tags

Research organism

Further reading

    1. Cancer Biology
    2. Developmental Biology

    Carcinogenesis: At the double for tumor suppressor

    Mahendra Sonawane
    Insight

    Research on zebrafish reveals how a tumor suppressor works in two different types of cells, and how hypotonic stress promotes tumor formation when the function of this tumor suppressor is lost.

    1. Cancer Biology
    2. Cell Biology

    Exosomes: How tumors escape the immune system

    Stefanie Schmieder
    Insight

    Mutations in the gene for β-catenin cause liver cancer cells to release fewer exosomes, which reduces the number of immune cells infiltrating the tumor.

    1. Cancer Biology
    2. Cell Biology

    mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated ubiquitination of eIF4A1 in cancer cells

    Dongyue Jiao, Huiru Sun ... Kun Gao
    Research Article

    Enhanced protein synthesis is a crucial molecular mechanism that allows cancer cells to survive, proliferate, metastasize, and develop resistance to anti-cancer treatments, and often arises as a consequence of increased signaling flux channeled to mRNA-bearing eukaryotic initiation factor 4F (eIF4F). However, the post-translational regulation of eIF4A1, an ATP-dependent RNA helicase and subunit of the eIF4F complex, is still poorly understood. Here, we demonstrate that IBTK, a substrate-binding adaptor of the Cullin 3-RING ubiquitin ligase (CRL3) complex, interacts with eIF4A1. The non-degradative ubiquitination of eIF4A1 catalyzed by the CRL3IBTK complex promotes cap-dependent translational initiation, nascent protein synthesis, oncogene expression, and cervical tumor cell growth both in vivo and in vitro. Moreover, we show that mTORC1 and S6K1, two key regulators of protein synthesis, directly phosphorylate IBTK to augment eIF4A1 ubiquitination and sustained oncogenic translation. This link between the CRL3IBTK complex and the mTORC1/S6K1 signaling pathway, which is frequently dysregulated in cancer, represents a promising target for anti-cancer therapies.